OLR1 and atherosclerosis: PCSK9 inhibition decreases the ROS production in endothelial cells and smooth muscle cells by inhibiting lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) expression in mice atherosclerosis models [169].